Machine Perfusion in Split Liver Transplantation: A Scoping Review
Abdullah Daher, Mohammed Naga, Konrad Kobryń, Michał GrątBackground.
Split liver transplantation (SLT) maximizes donor organ utilization but faces challenges with ischemia-reperfusion injury (IRI). Machine perfusion techniques, including hypothermic oxygenated perfusion (HOPE), dual HOPE (DHOPE), and normothermic machine perfusion (NMP), may enhance graft viability and expand the donor pool. This scoping review maps existing clinical and experimental evidence on machine perfusion in SLT, examining benefits, feasibility, outcomes, and knowledge gaps.
Methods.
Following Joanna Briggs Institute manual guidelines, we searched PubMed, Embase, Scopus, and Web of Science through September 3, 2025, plus gray literature (ClinicalTrials.gov, WHO International Clinical Trials Registry Platform, Google Scholar). Studies exploring machine perfusion techniques in liver splitting of human or animal grafts, with or without transplantation, were included.
Results.
After screening 958 records, 38 studies were included (29 primary studies, 9 reviews). Among primary studies, 84 clinical transplant cases using machine perfusion were identified (including 2 cases with unspecified perfusion modality); however, this number may not represent unique patients because of possible overlap between same-center cohorts. HOPE (7 studies, 40 cases) was supported by preliminary comparative data suggesting reduced IRI versus static cold storage, with 1 cohort study showing lower postreperfusion syndrome rates (13.3% versus 47.1%,
Conclusions.
Machine perfusion remains an investigational strategy in SLT. Preliminary evidence suggests HOPE may reduce IRI and NMP may provide logistical advantages through extended preservation. However, evidence derives entirely from small observational studies without randomization. Multicenter prospective studies with standardized protocols, longer follow-ups, and cost-effectiveness analyses are needed.